Retatrutide: Unlike semaglutide, retatrutide is a triple hormone receptor agonist targeting GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
You can always adjust your timing or switch to taking it with meals if needed
Where earlier-generation incretin peptides target one or two of these pathways, retatrutide engages all three
Bimagrumab: Blocking Myostatin and Activin Type II Receptors Bimagrumab is a monoclonal antibody, which means it is a type of protein made in the lab that can bind to specific targets in the body
Quva also highlighted BrightStream, an AI-enabled platform that aggregates and normalizes fragmented health-system data to support the drug-shortage management, inventory optimization, diversion reduction, and formulary decision-making